R.PR
REGISTERED-PRINCIPAL REGISTER
11/16/2021
Back to search
Official data from USPTO
SPLENDRIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
11/16/2021
Trademark type
Combined
Nice classes
5
Filing date
12/17/2020
Registration date
11/16/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/16/2021
Last transaction
11/16/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
Shenzhen, Guangdong, CN
Examiner
MURRAY, GEORGE WILLIAM
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the literal element "SPLENDRIS" in stylized font.
Holders and representatives
Holders
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Representatives
Nazly Aileen Bayramoglu BAYRAMOGLU LAW OFFICES LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsfor treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseases; Chemico-pharmaceutical preparationsfor treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseases; Chemical preparations for pharmaceutical or medical purposesfor treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseases; Medicines for human purposefor treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseases; Medicated Trochesfor the prevention and treatment of disorders of the nervous systemthe immune systemthe cardiovascular systemthe cerebrovascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemdigestive systemendocrine systemfor the treatment of infective diseasesfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of pharmaceutical preparationswhich are used for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardiovascular systemthe cerebrovascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemdigestive systemendocrine systemfor the treatment of infective diseasesfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Medicinal herbal preparationsfor treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseases; Biochemical medicinesfor treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseasesPharmaceutical preparations for the treatment of heart rhythm disordersSynthetic peptides for the treatment of cardiovascular disease; Dietetic substances adapted for medical usebeverages and food in the nature of vitaminproteinmineralslecithinglucoseamino acidfolic acidfruit juicefruit oilhoneyseaweed gluefish oilcod-liver oilcubiloserestorativesplant fibrenutrition powdernutrient capsulenutrient tabletsmineral food-supplements used for treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseases; Drugs for medical purposesPharmaceutical products for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardiovascular systemthe cerebrovascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemdigestive systemendocrine systemfor the treatment of infective diseasesfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders
Publications
History of USPTO decisions and trademark events.
14 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/31/2021
PUBO
PUBLISHED FOR OPPOSITION
08/31/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/28/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/22/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/21/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/21/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/16/2021
GNRT
NON-FINAL ACTION E-MAILED
06/16/2021
CNRT
NON-FINAL ACTION WRITTEN
06/16/2021
DOCK
ASSIGNED TO EXAMINER
06/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/26/2021
NWAP
NEW APPLICATION ENTERED
12/21/2020
Continuous trademark protection
Get notified about every new filing that threatens SPLENDRIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.